NewEdge Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.74M Buy
75,655
+13,341
+21% +$677K 0.01% 893
2026
Q1
$3.32M Sell
62,314
-5,363
-8% -$315K 0.01% 861
2025
Q4
$4.21M Sell
67,677
-4,845
-7% -$299K 0.02% 735
2025
Q3
$4.36M Sell
72,522
-2,729
-4% -$167K 0.02% 688
2025
Q2
$4.71M Sell
75,251
-3,499
-4% -$210K 0.02% 589
2025
Q1
$4.74M Sell
78,750
-942
-1% -$58.5K 0.03% 523
2024
Q4
$4.65M Sell
79,692
-6,814
-8% -$405K 0.03% 527
2024
Q3
$5.12M Sell
86,506
-25,713
-23% -$1.47M 0.03% 465
2024
Q2
$6.29M Sell
112,219
-7,928
-7% -$444K 0.05% 381
2024
Q1
$7.04M Sell
120,147
-825
-0.7% -$46.6K 0.06% 295
2023
Q4
$6.64M Sell
120,972
-31,586
-21% -$1.54M 0.06% 289
2023
Q3
$7.4M Sell
152,558
-23,493
-13% -$1.25M 0.08% 243
2023
Q2
$9.94M Buy
176,051
+77,825
+79% +$4.29M 0.11% 183
2023
Q1
$5.37M Sell
98,226
-26,199
-21% -$1.39M 0.07% 285
2022
Q4
$4.2M Buy
124,425
+18,789
+18% +$953K 0.11% 194
2022
Q3
$4.98M Sell
105,636
-1,985
-2% -$103K 0.08% 234
2022
Q2
$5.43M Buy
107,621
+3,620
+3% +$197K 0.09% 219
2022
Q1
$6.34M Sell
104,001
-562
-0.5% -$33.5K 0.1% 201
2021
Q4
$6.88M Buy
104,563
+35,648
+52% +$2.28M 0.1% 191
2021
Q3
$4.33M Buy
68,915
+19,409
+39% +$1.24M 0.11% 188
2021
Q2
$2.98M Sell
49,506
-103,122
-68% -$5.96M 0.08% 237
2021
Q1
$8.4M Sell
152,628
-42,330
-22% -$2.35M 0.25% 92
2020
Q4
$10.6M Buy
194,958
+8,970
+5% +$469K 0.35% 67
2020
Q3
$9.29M Buy
185,988
+33,594
+22% +$1.63M 0.32% 84
2020
Q2
$6.72M Buy
152,394
+108,270
+245% +$4.63M 0.26% 92
2020
Q1
$1.66M Sell
44,124
-978
-2% -$41.2K 0.08% 231
2019
Q4
$1.99M Sell
45,102
-3,168
-7% -$133K 0.08% 246
2019
Q3
$1.99M Buy
48,270
+10,440
+28% +$427K 0.09% 219
2019
Q2
$1.52M Sell
37,830
-3,984
-10% -$151K 0.09% 213
2019
Q1
$1.61M Buy
41,814
+8,376
+25% +$304K 0.1% 201
2018
Q4
$1.11M Buy
33,438
+9,882
+42% +$342K 0.07% 238
2018
Q3
$893K Buy
+23,556
New +$837K 0.07% 248

Other funds holding IHI

NewEdge Advisors's IHI Position: Q2 2026 in Review

NewEdge Advisors increased its iShares US Medical Devices ETF (IHI) stake by 21% in Q2 2026, buying an estimated $677K and bringing the position to 75,655 shares worth $3.74M. The position accounts for 0.01% of the portfolio, ranked #893.

NewEdge Advisors first reported a position in IHI in Q3 2018 and has held it in 32 quarters since. The position peaked at $10.6M in Q4 2020. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • NewEdge Advisors held 75,655 shares of iShares US Medical Devices ETF worth $3.74M as of Q2 2026.
  • NewEdge Advisors bought 13,341 iShares US Medical Devices ETF shares in Q2 2026, an estimated $677K.
  • iShares US Medical Devices ETF made up 0.01% of NewEdge Advisors's portfolio in Q2 2026, its #893 holding.
  • NewEdge Advisors first reported a position in iShares US Medical Devices ETF in Q3 2018 and has held it in 32 quarters since.
  • NewEdge Advisors's iShares US Medical Devices ETF position peaked at $10.6M in Q4 2020.
  • 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.